Carraway, Robert E <br/><br/>
Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Nov 2003 
 - 640-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.102.052688  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Binding Sites<br/>Calcium--pharmacology<br/>Calcium Channel Blockers--pharmacology<br/>Endocytosis<br/>Enzyme Inhibitors--pharmacology<br/>Epidermal Growth Factor--metabolism<br/>Humans<br/>Inositol Phosphates--metabolism<br/>Iodine Radioisotopes<br/>Male<br/>Neurotensin--metabolism<br/>Nifedipine--pharmacology<br/>Photoaffinity Labels<br/>Prostatic Neoplasms--pathology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Neurotensin--metabolism<br/>Tumor Cells, Cultured